• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Industry
    • Exhibits and Support & Visibility Opportunities
    • Industry Archives
  • Meetings
    • 2026 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2025 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2025 Proffered Presentations

2025 Proffered Presentations

 

← Back to Previous Page

 

S292: DISCOVERY OF A NOVEL CEREBROSPINAL FLUID-SPECIFIC DNA APTAMER
Arash Abiri; Xinlei Chen; Brandon Latifi; Frank Hsu; Andrej Luptak; Michelle Khine; Edward Kuan; UC Irvine

Background: Cerebrospinal fluid (CSF) leaks present a significant problem for neurosurgical, otolaryngologic, trauma, and emergency medicine patients. However, determining the presence of a CSF leak currently depends largely on clinical suspicion since gold standard testing for CSF via immunofixation electrophoresis can be time-consuming and typically only available in specialized, centralized laboratories. With the goal of developing a bedside electrochemical-based diagnostic tool for CSF detection, we hereby aimed to develop a novel single-stranded deoxyribonucleic acid (ssDNA) aptamer capable of selectively binding to CSF-specific biomarkers.

Methods: To identify a candidate aptamer, we performed Systematic Evolution of Ligands by EXponential enrichment (SELEX) using a large and diverse random sequence DNA library. This pool of DNA sequences contained a 63-nucleotide (nt) stretch of random sequences flanked by two primer-binding sites, which were further modified to possess methylene blue (MB) at their 5’ terminus to serve as a redox indicator in electrochemical measurements. Quantitative polymerase chain reaction (qPCR) was used to evaluate aptamer binding affinity.

Results: Fourteen cycles of SELEX were performed, after which high-resolution sequencing of the resulting DNA pool revealed 2 dominant and functionally viable 98-nt ssDNA (C2 and C3). Processing of the synthesized ssDNA using complex samples of CSF or plasma, followed by qPCR analysis, demonstrated that C2 and C3 expressed ~586x and ~82x higher affinity for CSF compared to plasma (both p<0.001).

Conclusions: In vitro selection of a diverse pool of ssDNA sequences revealed two aptamers with high selectivity for CSF-specific biomarkers. Integration of these aptamers into an electrochemical platform enables the development of a point-of-care diagnostic device for detecting CSF leaks.

 

← Back to Previous Page

Copyright © 2025 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved